Obiettivo Neuromuscular diseases (NMD) such as Dystrophies, Atrophies, Paralysis or Neuropathies are a group of more than 150 genetic illnesses affecting the lower neuromotor system, which include the muscles and nerves system. NMDs share the common traits of childhood onset and progressive muscle weakness, which lead to walk disability, loss of autonomy and psychosocial consequences. There is currently not treatment available to halt the progressive course of these NMDs. Most therapeutic approaches are limited to medicines (by reducing symptoms) and musculoskeletal rehabilitation in-clinic programs, as neurological disorders main feature is the loss of muscles strength and a progressive lack of walking. The key is maintaining walking ability for slowing the deterioration caused by permanent sitting, giving hope for a better and more independent life. Marsi Bionics offers an innovative approach: Wearable Gait Exoskeletons as and effective 24/7 in-house therapy solution for allowing NMD children to walk.ATLAS 2020 is the first paediatric exoskeleton we developed for using in hospitals/rehabilitation centres. Our purpose and why we need and expert in biomechanics is to get ready a more advanced version, ATLAS 2030 for expanding rehabilitation to home and activities of daily living, building a paradigm for NMD rehabilitation. To achieve this goal we are working on providing self-balance capabilities to the exoskeleton. The company is looking for a qualified biomechanical engineer with an excellent background in human locomotion for improving ergonomics and biomechanics of gait balance of our bionics exoskeletons and to analyse the gait dysfunctions from NMD pathologies. The potential Marsi Bionics would achieve improving ATLAS 2030, by accomplishing the ideal ergonomics aspects related to each NMD mobility pattern during the gait by recruiting an expert in Biomechanics, will reinforce research in robotic area for health and will create new market opportunities. Campo scientifico medical and health sciencesclinical medicinephysiotherapymedical and health sciencesbasic medicineneurologymuscular dystrophiesduchenne muscular dystrophymedical and health sciencesbasic medicinepathologynatural sciencesbiological sciencesbiophysicssocial sciencespsychologyergonomics Programma(i) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs Argomento(i) INNOSUP-02-2016 - European SME innovation Associate - pilot Invito a presentare proposte H2020-INNOSUP-2016-2017 Vedi altri progetti per questo bando Bando secondario H2020-INNOSUP-02-2016 Meccanismo di finanziamento CSA - Coordination and support action Coordinatore MARSI BIONICS SL Contribution nette de l'UE € 103 300,00 Indirizzo CALLE RUE DEL PERCEBE 30 28521 RIVAS VACIAMADRID Spagna Mostra sulla mappa PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì Regione Comunidad de Madrid Comunidad de Madrid Madrid Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Collegamenti Contatta l’organizzazione Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 103 300,00
